West Virginia Rx drug program reports success

27 July 2008

A US state-run prescription drug program for uninsured residents is expected to enroll 10,000 people in its first year, according to the local Charleston Gazette. The West Virginia Rx scheme, which covers one of the poorer US states, is open to people aged 18 to 65 on less than twice the federal poverty level. Medicines are donated by drugmakers and a $30 fee per year is charged. The program's Director, Barbara Dane argues that the state saves on hospital bills.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight